Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) traded at $3.0 at last check on current trade day and made a downward move of -19.14% on its previous day’s price.
Looking at the stock we see that its previous close was $3.71 and the beta (5Y monthly) reads 0.368 with the day’s price range being $2.75 – $3.335. In terms of its 52-week price range, LIXT has a high of $4.45 and a low of $0.64. The company’s stock has gained about 163.16% over that past 30 days.
Lixte Biotechnology Holdings Inc has a market cap of $8.68 million and is expected to release its quarterly earnings report in August.
On the other hand, looking at the outlook for the LIXT stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of Hold.
Looking further, we note the current price level is 52.68% off its SMA20 and 91.75% from its 50-day simple moving average. The RSI (14) is pointing at 58.85 while the volatility over the past week is 32.24% and jumps to 32.09% over the past one month.
Coming back to Lixte Biotechnology Holdings Inc (NASDAQ:LIXT), we note that the average 3-month trading volume was 2.07 million, while that of the preceding 10-day period stands at 12.35 million. Current shares outstanding are 2.68 million.
The insiders hold 22.33% of the company’s shares while institutions hold 10.36%. The data shows that short shares as of 2025-06-13, stood at 4456.0 at a short ratio of 0.16. This represents a 16.00 short interest in shares outstanding on 2025-06-13. Shares short fall in June from the previous month at 32595.0. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 26.58% up in year-to-date price movement.
